Publications by authors named "Christopher J Talbot"

Claim this Profile
U
Unveiling regions associated with acute and late breast side-effects from breast radiotherapy using voxel-wise image-based data mining analysis.
Tanwiwat Jaikuna, Fiona Wilson, Carmel Anandadas, David Azria, Jenny Chang-Claude, Christopher J Talbot

Radiother Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories and risk factors for long-term breast symptoms following breast-conserving surgery and radiotherapy: a single centre analysis.
Catherine Jones, Nur Nurmahomed, Monika Kaushik, Jaroslaw Krupa, Kelly V Lambert, Christopher J Talbot

Support Care Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy.
Elke Rammant, Emile Deman, Valérie Fonteyne, Lindsay Poppe, Renée Bultijnck, Christopher J Talbot

Health Qual Life Outcomes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy.
Ester Aguado-Flor, Victoria M Reyes, Víctor Navarro, Meritxell Mollà, Miguel E Aguado-Barrera, Christopher J Talbot

Breast· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.
Manzur Farazi, Xin Yang, Carson J Gehl, Gillian C Barnett, Neil G Burnet, Christopher J Talbot

Cancer Epidemiol Biomarkers Prev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study.
Miguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, Patricia Calvo-Crespo, Begoña Taboada-Valladares, Christopher J Talbot

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising inter-patient image registration for image-based data mining in breast radiotherapy.
Tanwiwat Jaikuna, Fiona Wilson, David Azria, Jenny Chang-Claude, Maria Carmen De Santis, Christopher J Talbot

Phys Imaging Radiat Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.
Tanwiwat Jaikuna, Eliana Vasquez Osorio, David Azria, Jenny Chang-Claude, Maria Carmen De Santis, Christopher J Talbot

Breast· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Harkeran K Jandu, Colin D Veal, Laura Fachal, Craig Luccarini, Miguel E Aguado-Barrera, Christopher J Talbot

Radiother Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.
Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Christopher J Talbot

JNCI Cancer Spectr· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Gillian C Barnett, Sarah L Kerns, Leila Dorling, Laura Fachal, Miguel E Aguado-Barrera, Christopher J Talbot

Int J Radiat Oncol Biol Phys· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
Lotte van der Weijst, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Christopher J Talbot

Radiother Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.
Adam J Webb, Emily Harper, Tim Rattay, Miguel E Aguado-Barrera, David Azria, Christopher J Talbot

EBioMedicine· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.
Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Christopher J Talbot

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Christopher J Talbot

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.
Sarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, Derick R Peterson, Brian Marples, Christopher J Talbot

Radiother Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.
Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, Samuel Ingram, Robert Lyon, Christopher J Talbot

Adv Radiat Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy.
Mahmoud Aldraimli, Daniele Soria, Diana Grishchuck, Samuel Ingram, Robert Lyon, Christopher J Talbot

Comput Biol Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Christopher J Talbot

Radiother Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort.
Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, Paolo Zunino, Christopher J Talbot

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.
Tim Rattay, Petra Seibold, Miguel E Aguado-Barrera, Manuel Altabas, David Azria, Christopher J Talbot

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Petra Seibold, Adam Webb, Miguel E Aguado-Barrera, David Azria, Celine Bourgier, Christopher J Talbot

Radiother Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity.
Christopher J Talbot, Marlon R Veldwijk, David Azria, Chiara Batini, Miriam Bierbaum

Clin Transl Radiat Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental analysis of SV2 in the embryonic chicken corneal epithelium.
Christopher J Talbot, James K Kubilus

Exp Eye Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.
David Azria, Ariane Lapierre, Sophie Gourgou, Dirk De Ruysscher, Jacques Colinge, Christopher J Talbot

Front Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis